Avertix’s Guardian System Confirmed as Cost-Effective for High-Risk Acute Coronary Syndrome Patients

EATONTOWN, N.J., Feb. 14, 2025 /PRNewswire/ — Avertix Medical, Inc. (“Avertix” or the “Company”), the developer of The Guardian® system – the world’s first real-time, continuous heart attack detection and patient alerting system today announced compelling new data confirming the…